Nurix Therapeutics Inc Asset Turnover Ratio (NRIX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nurix Therapeutics Inc   (NASDAQ: NRIX)
 

Nurix Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Nurix Therapeutics Inc 's asset turnover ratio, the ratio that measures the ability of Nurix Therapeutics Inc 's assets to generate revenue, sequentially decreased to 0.06 in the second quarter (May 31 2026), which does not come as a surprise, as the Nurix Therapeutics Inc continue to experience difficult business climate.

Within sector 169 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 3138, from total ranking in the first quarter 2026 at 3715.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NRIX Asset Turnover Ratio (May 31 2026)
II. Quarter		 (Feb 28 2026)
I. Quarter		 (Nov 30 2025)
IV. Quarter		 (Aug 31 2025)
III. Quarter		 (May 31 2025)
II. Quarter
Y / Y Asset Change -9.47 % 3.43 % 2.81 % 1.82 % 15.76 %
Y / Y Revenue Change -79.47 % -66.12 % 2.21 % -37.29 % 264.34 %
Asset Turnover Ratio (TTM) 0.06 0.12 0.14 0.14 0.15
NRIX's Total Ranking # 3138 # 3715 # 3145 # 3170 # 3422
Seq. Asset Change -15.81 % -7.56 % 31.71 % -11.68 % -3.82 %
Seq. Revenue Change 44.64 % -53.95 % 71.99 % -82.08 % 138.75 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 170
Healthcare Sector # 498
Overall Market # 3138

Asset Turnover Ratio Statistics
High Average Low
0.24 0.12 0.05
(Feb 29 2024)   (May 31 2021)




NRIX Company Profile • Back to NRIX Efficiency Comparisons • Compare NRIX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending May 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending May 31 2026 Assets at quarter ending May 31 2026
4d Molecular Therapeutics Inc   0.18 $ 92.008  Millions$ 499.053  Millions
Nrx Pharmaceuticals Inc   0.18 $ 3.394  Millions$ 18.504  Millions
Lexicon Pharmaceuticals Inc   0.18 $ 41.469  Millions$ 227.448  Millions
Bioadaptives Inc   0.18 $ 0.026  Millions$ 0.141  Millions
Foghorn Therapeutics Inc   0.18 $ 36.739  Millions$ 207.156  Millions
Renovorx Inc   0.18 $ 1.976  Millions$ 11.184  Millions
Coya Therapeutics Inc   0.18 $ 8.019  Millions$ 45.643  Millions
Ligand Pharmaceuticals Incorporated  0.17 $ 290.542  Millions$ 1,688.847  Millions
Septerna Inc   0.17 $ 98.882  Millions$ 584.816  Millions
Inspiremd Inc   0.17 $ 10.502  Millions$ 62.247  Millions
Coherus Oncology inc   0.17 $ 50.936  Millions$ 308.017  Millions
Prelude Therapeutics Inc  0.16 $ 22.424  Millions$ 136.269  Millions
Prothena Corporation Public Limited Company  0.16 $ 54.530  Millions$ 332.976  Millions
Opus Genetics Inc   0.16 $ 9.856  Millions$ 61.530  Millions
Skinvisible Inc   0.16 $ 0.020  Millions$ 0.126  Millions
Maxcyte inc   0.16 $ 31.051  Millions$ 198.782  Millions
Abeona Therapeutics Inc   0.15 $ 30.093  Millions$ 207.166  Millions
Voyager Therapeutics Inc   0.14 $ 34.459  Millions$ 239.417  Millions
Standard Biotools Inc   0.14 $ 83.691  Millions$ 593.430  Millions
Femasys Inc   0.14 $ 2.299  Millions$ 16.450  Millions
Seastar Medical Holding Corp  0.14 $ 1.713  Millions$ 12.400  Millions
Sintx Technologies Inc   0.14 $ 1.330  Millions$ 9.778  Millions
Xencor Inc  0.13 $ 104.973  Millions$ 801.528  Millions
Lucid Diagnostics Inc   0.13 $ 5.445  Millions$ 41.667  Millions
Royalty Pharma Plc  0.13 $ 2,535.998  Millions$ 19,650.812  Millions
Omniab Inc   0.13 $ 38.457  Millions$ 298.628  Millions
Lineage Cell Therapeutics Inc   0.13 $ 13.083  Millions$ 104.494  Millions
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
Kura Oncology Inc   0.12 $ 77.225  Millions$ 657.022  Millions
Arcus Biosciences Inc   0.12 $ 117.000  Millions$ 1,008.500  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.